HORAK IVAN D 4
4 · ENZON PHARMACEUTICALS INC · Filed Apr 5, 2011
Insider Transaction Report
Form 4
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
- Tax Payment
Common Stock
2011-04-03$11.02/sh−9,380$103,368→ 138,476 total - Exercise/Conversion
Common Stock
2011-04-03+26,480→ 147,856 total - Exercise/Conversion
Restricted Stock Units
2011-04-03−16,800→ 0 totalExercise: $0.00From: 2011-04-03Exp: 2011-04-03→ Common Stock (16,800 underlying)
Footnotes (2)
- [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
- [F2]The Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.